Demand for Outsourcing Biologics Fill Finish Services

The increasing demand for biologics has led to an increasing need for production capacity, which is characterized by high quality standards.

Although, it is a challenging field, outsourcing has emerged as a promising segment, especially for drug product manufacturing and aseptic fill / finish operations. Despite being one of the crucial steps of all the steps involved in the production of biologics, fill finish is heavily outsourced activities in the pharmaceutical industry. Currently, it is estimated that more than 50% of the overall operations are outsourced to service providers. Service providers offering these services are using vials for filling of biologics. Of these, over 70% of service providers operate at clinical and commercial scales of operation. Of the players offering these services for biologics are headquartered in Asia-Pacific. More than 35% of these players are located in China. Further, of these, more than 40% players are well established players.

For additional details, please visit https://www.rootsanalysis.com/....blog/demand-for-outs

Please log in to like,share and comment !

EXPLORE MORE INTEREST